相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
Jordi Guitart et al.
DRUGS IN R&D (2018)
Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study
Jordi Guitart et al.
DRUGS IN R&D (2017)
Guidelines for the Management of Breakthrough Pain in Patients With Cancer
Augusto Caraceni et al.
Journal of the National Comprehensive Cancer Network (2017)
Italian Oncological Pain Survey (IOPS) A Multicentre Italian Study of Breakthrough Pain Performed in Different Settings
Sebastiano Mercadante et al.
CLINICAL JOURNAL OF PAIN (2015)
Breakthrough Pain in Elderly Patients with Cancer: Treatment Options
Sophie Pautex et al.
DRUGS & AGING (2014)
Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice
Juan A. Virizuela et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain
Michael A. Ueberall et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
The Declaration Montreal: Access to pain management is a fundamental human right
M. J. Cousins et al.
PAIN (2011)
Substance Abuse in Cancer Pain
Tatiana D. Starr et al.
CURRENT PAIN AND HEADACHE REPORTS (2010)
Fentanyl Sublingual In Breakthrough Pain in Opioid-Tolerant Adults with Cancer
Claudine M. Chwieduk et al.
DRUGS (2010)
Breakthrough Pain in Oncology: A Longitudinal Study
Sebastian Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study
Bo Lennernas et al.
PALLIATIVE MEDICINE (2010)
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
Richard L. Rauck et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland
Andrew N. Davies et al.
EUROPEAN JOURNAL OF PAIN (2009)
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
Russell K. Portenoy et al.
CLINICAL JOURNAL OF PAIN (2006)
Cancer-related breakthrough pain
Andrew N. Davies
BRITISH JOURNAL OF HOSPITAL MEDICINE (2006)
Fentanyl buccal tablet - In breakthrough pain in opioid-tolerant patients with cancer
Stephanie K. A. Blick et al.
DRUGS (2006)
Breakthrough pain in malignant and non-malignant diseases:: a review of prevalence, characteristics and mechanisms
KB Svendsen et al.
EUROPEAN JOURNAL OF PAIN (2005)
A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients
RL Fainsinger et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients:: a new approach to treatment of incident pain
B Lennernäs et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey
A Caraceni et al.
PALLIATIVE MEDICINE (2004)
Nasal administration of opioids for pain management in adults
O Dale et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2002)
Oral mucosal drug delivery - Clinical pharmacokinetics and therapeutic applications
H Zhang et al.
CLINICAL PHARMACOKINETICS (2002)
Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)
PH Coluzzi et al.
PAIN (2001)
The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug
S Sundell-Bredenberg et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
The prevalence of episodic pain in cancer: a survey of hospice patients on admission
M Swanwick et al.
PALLIATIVE MEDICINE (2001)
Evaluation of the genetic component of variability in CYP3A4 activity:: a repeated drug administration method
V Özdemir et al.
PHARMACOGENETICS (2000)
分享论文
